通过FAERS的Nirmatrelvir/Ritonavir对不良药物事件信号的数据挖掘
Ji Sun1,2, Xuanyu Deng1,2, Juanjuan Huang1,2
1The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
PloS one
|December 31, 2024
概括
用于COVID-19的尼尔马特里尔维尔/里托纳维尔显示出已知的副作用,如腹和腹. 在现实世界的数据中发现了新的潜在不良药物事件,包括白的便和黄色的皮肤.
科学领域:
- 药物监督 药物监督 药物监督
- 传染性疾病 传染性疾病
- 药品安全 药品安全
背景情况:
- 尼尔马特里尔维尔/里托纳维尔是一种有效的COVID-19抗病毒药物,但其药物安全性需要进一步调查.
- 现有的关于尼尔马特里尔维尔/里托纳维尔不良反应的研究是有限的,需要对现实世界的数据进行分析.
研究的目的:
- 使用FDA不良事件报告系统 (FAERS) 数据库识别和分析与尼马特里尔维尔/里托纳维尔相关的不良反应信号.
- 为在COVID-19治疗中安全合理使用尼尔马特里尔维尔/里托纳维尔提供基础.
主要方法:
- 利用FAERS数据库,分析了所有COVID-19紧急使用授权 (EUA) 产品的不良药物事件 (ADE) 报告,直到2023年第三季度.
- 采用报告几率比率 (ROR) 方法来检测重大不良事件信号.
- 集中分析了35,250份关于Nirmatrelvir/Ritonavir是主要可疑药物的ADE报告.
主要成果:
- 观察到高信号强度的疾病 (ROR = 72.98),腹 (ROR = 3.03),和头痛 (ROR = 1.25),与已知的副作用一致.
- 确定了新的潜在不良反应,包括浅色便 (ROR = 45.53),色素 (ROR = 3.07),皮肤黄色 (ROR = 3.62) 和舌头涂层 (ROR = 35.55).
- 这些发现补充了药物说明书中未列出的已知ADEs.
结论:
- 该研究确定了尼尔马特里尔维尔/里托纳维尔的显著不良反应信号,包括以前未经记录的事件.
- 这些发现凸显了临床关注尼尔马特里尔维尔/里托纳维尔潜在不良药物事件 (ADEs) 的重要性.
- 这项研究为临床实践中尼尔马特里尔维尔/里托纳维尔的安全有效应用提供了理论基础.
相关概念视频
Pharmacovigilance
730
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
730
Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K


